Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Long COVID patients have more health issues than non-infected people.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Alopecia areata causes varying hair loss patterns, affecting hair, nails, and possibly glands, with treatment outcomes depending on disease duration and extent.

Nanoparticles show potential for controlled release of hair loss drugs, improving treatment effectiveness.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Immunizing goats against melatonin can temporarily change their cashmere growth cycles and increase fleece production.

A rare scalp disease causes hair loss, pus-filled nodules, and scarring.

PRP and cell therapies may help with hair loss, but more research is needed.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Transfollicular drug delivery is promising but needs more research to improve and understand it better.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Careful management of blood thinners is crucial for lupus patients with APS.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Ethosomal carriers effectively deliver hair loss drug into skin.

Blocking interferon-gamma might help treat various autoimmune diseases.